Lupin debuts authorized generic of Alinia
Nitazoxanide tablets had a market value of $56 million, according to IQVIA January 2021 data.
Lupin is introducing nitazoxanide tablets in a dosage strength of 500 mg.
The product is the authorized generic of Romark’s Alinia.
Nitazoxanide tablets are indicated for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 12 years of age and older.
Nitazoxanide tablets had a market value of $56 million, according to IQVIA January 2021 data.